Skip to main content
. 2017 Oct 26;8(58):97811–97821. doi: 10.18632/oncotarget.22083

Figure 6. AKT inhibitor MK2206 restrains the oncogenic role of CAPN2-OV in RCC cells.

Figure 6

(A) and (B) The promoting role of CAPN2-OV on migration and invasion of CAKI-2 cells was attenuated after adding MK2206. (C) The promoting role of CAPN2-OV on proliferative potential of CAKI-2 cells was inhibited by MK2206. Data are mean ± SD of at least three independent experiments, *P < 0.05.